O-2372 is an analgesic cannabinoid derivative created by Organix Inc. for use in scientific research. It has high affinity for both CB1 and CB2 receptors with Ki values of 1.3nM at CB1 and 0.57nM at CB2 but is only moderately soluble in water compared to other related compounds such as O-2694 which it is a metabolite of.
This page contains content from the copyrighted Wikipedia article "O-2372"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
